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Background: Grasses and olive trees are the most common sources of allergenic pollen worldwide. Although they
share some allergens, there are few studies analyzing the in vitro cross-reactivity between them. The aim was to
define the cross-reactivity between Olea europaea and Phleum pratense using well-characterized sera of allergic
children from Madrid, Spain.
Methods: 66 patients (mean age 10.32+/−4.07 years) were included in the study. All suffered from
rhinoconjuntivitis and/or asthma and had a positive skin test and/or specific IgE determination to olive and
grass pollen. Serum sIgE to individual allergens was conducted and sIgE against different grass species and olive
was also determined by ELISA. Inhibition assays were performed using two serum sources, containing, or not,
sIgE to minor allergens. Mass spectrometry analysis was performed in both extracts.
Results: 59/66 (89.39%) children had a positive sIgE determination by ELISA to grasses and 57/66 (86.36%) to
olive pollen. There was no significant correlation between sIgE levels to grass and olive. Inhibition assays
demonstrated no cross-reactivity between P. pratense and olive pollen when using the pool containing mainly
sIgE to major allergens, whereas minimal to moderate cross-reactivity was detected when the serum contained
high sIgE titers to minor allergens. Proteomic analyses revealed the presence of 42 common proteins in grasses
and olive pollens.
Conclusion: No in vitro cross-reactivity was observed when sIgE was mainly directed to major allergens. In our
population, sensitization to olive and grasses is not due to cross-reactivity. The contribution of the major allergens
seems to be determinant.
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Allergy to grasses is the most important cause of pollinosis
worldwide. Eleven allergen groups have been described in
grasses [1]. Groups 1 (Subfamily of b-expansins) and 5
(heterogeneous proteins with ribonuclease activity) consti-
tute the most immunodominant allergens with the highest
prevalence of IgE binding and greatest sIgE binding cap-
acity in children [2,3]. Groups 2, 3, 4 (berberine bridge en-
zymes) [4], 6, 7 (calcium binding proteins), 10 (cytochrome* Correspondence: bcases@inmunotek.com; efcaldas@inmunotek.com
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reproduction in any medium, provided the orc), 11 (trypsin inhibitor, Ole e 1-related protein), 12 (profi-
lins) and 13 (polygalacturonase) are also important aller-
gens. However, Phl p 4, 7, 11, and 12 are not grass-specific.
Sensitization to olive pollen is also an important cause
of pollinosis in Mediterranean countries and in the United
States of America, especially in California [5]. Currently,
13 allergens have been described in O. europaea; 12 from
pollen and one (thaumatin) as a food allergen from the
olive fruit [6]. Ole e 1 is the major allergen, recognized by
more than 70% of olive sensitized patients [7] and it has
been proposed as a diagnostic marker for primary
sensitization to Oleaceae [8]. Other allergens, such as pro-
filin (Ole e 2), polcalcins (Ole e 3, Ole e 8), glucanasestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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transfer proteins (Ole e 7), glycosyl hydrolases (Ole e 10),
pectin methylesterase (Ole e 11), and Ole e 6, whose bio-
logical function is still unknown, have also been described.
Panallergens are responsible of a large number of cross-
reactivity reactions among different species. Regarding a
potential cross-reactivity between olive and grasses, the
most likely implicated proteins are trypsin inhibitors, pro-
filins and calcium binding proteins [9,10] corresponding
to Ole e 1, Ole e 2, Ole e 3 and Ole e 8 in O. europaea
and to groups 11, 12 and 7 in grasses. The scarce bibliog-
raphy investigating cross-reactivity between grasses and
O. europaea, suggests cross-reactivity between olive pollen
and non-related species, including grass pollens [11,12].
Grasses and olive trees pollinate approximately at the
same time in Spain. Therefore, to decide which one these
pollens is producing clinical symptoms in polysensitized
patients is complicated. However, we have previously
demonstrated that olive and grass pollen mono-sensitized
patients exhibit clinical symptoms during their respective,
overlapping pollen seasons, suggesting the clinical rele-
vance of these sensitizations [13,14].
The main objective of this study was to analyze cross-
reactivity between olive and grass pollen extracts using
well characterized sera of children in an area where both
allergens are clinically relevant and endemic.Methods
Patient population
Sixty six pediatric patients, 47 males (71.21%), with a
mean age of 10.32 years ± 4.07 SD, consecutively evalu-
ated in the outpatient clinic at the Niño Jesús Hospital,
Madrid, Spain, were entered in the study. They were in-
cluded if they fulfilled the following criteria: 1) less than
18 years, 2) a clinical history of allergic rhinoconjunctivi-
tis and/or asthma during the grass and olive pollen season
(May-June) of two years or more requiring treatment and
3) positive SPT and/or sIgE against grass and olive pollen.
Oral and written consent was obtained from the parents,Table 1 Summary of the results of the sIgE determinations by
A
SPT P. pratense
Patients tested 65 (98.48%)
Positive patients 65 (100%)
B
InmunoCAP P. pratense rPhl p 1 rPhl p 5
Patients tested 57 (86.36%) 55 (83.33%) 55 (83.33%)
Positive patients 57 (100%) 52 (95.55%) 32 (58.18%)
Results are expressed in percentage of positives.and by the patient if older than 12 years of age, to donate
a blood sample to perform sIgE determinations related to
their allergies. Exclusion criteria were previous treatments
with immunotherapy with grass and/or olive extracts.
Protocol number INM-RCA-2011-01 received IRB ap-
proval to be conducted.Skin tests and sIgE determination by ImmunoCap
Skin tests with a commercial battery of inhalant aller-
gens including different grasses (Phleum, Lolium and
Cynodon), olive pollen, palm tree profilin, dust mites,
molds and animal dander (ALK-Abelló, Madrid, Spain)
were performed to all patients using disposable 1 mm
tip lancets. Results were read after 15 minutes, and a
wheal diameter of 3 mm, or greater, was considered
positive. Histamine (10 mg/mL) and saline SPT were
used as positive and negative controls [15] (Table 1).
Serum sIgE determinations to Phleum Pratense, Olea
europaea and individual allergens (rPhl p 1, rPhl p 5,
rPhl p 7, rPhl p 12 and nOle e 1) were performed by the
CAP-System FEIA TM (Thermofisher Scientific, Spain).
Results were considered positive when sIgE levels were
above 0.35 kUA/l (Table 1). These analyses were part of
the routine evaluation of the patients.Extracts for ELISA and ELISA Inhibition determinations
Protein extracts from O. europaea and P. pratense were
obtained from acetone defatted pollens (IberPolen, Jaén,
Spain). Briefly, extractions were performed 1:40 (w/v) in
PBS buffer for 12 hours at 4°C under magnetic stirring
conditions. After centrifugation at 10,000 rpm for 15 mi-
nutes, pellets were discarded and the supernatants ster-
ile filtered through 0.22 μm cellulose acetate filters
(Sartorius Stedim, Göttingen Germany). Extracts were dia-
lyzed by ultrafiltration using a 5 kDa membrane (Pall, NY,
USA) and freeze dried. The protein content was deter-
mined by the Bradford assay [16]. The protein concentra-
tion was 2.27 mg/ml for O. europaea and 5.4 mg/ml for
P. pratense.SPT (A) and InmunoCap system (B)
O. europaea Palm profilin
65 (98.48%) 46 (69.69%)
63 (96.92%) 19 (41.30%)
rPhl p 7 rPhl p 12 O. europaea nOle e 1
43 (65.15%) 45 (68.18%) 55 (83.33%) 55 (83.33%)
6 (13.95%) 14 (31.11%) 55 (100%) 52 (96.92%)
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ELISA and ELISA inhibition assays were conducted in
96-well plates (Microlon, high binding, Greiner bio-one,
Germany). Briefly, 1 μg of protein per well diluted in
coating buffer (0.05 M carbonate bicarbonate buffer
pH = 9.6) was used as solid phase. Plates were incu-
bated overnight at 4°C, washed with PBS-tween 0.25%
and blocked for 1 hour with PBS containing 0.25%
Tween-20 and 2% BSA. Individual sera were added di-
luted 1/2 in blocking buffer and incubated for 2 hours
at RT. Finally, plates were washed and incubated with
a monoclonal mouse antihuman IgE peroxidase conju-
gated antibody (Southern Biotech, USA) diluted 1:2000
in blocking buffer. IgE reactivity was detected by the
addition of OPD (Sigma-Aldrich, USA). Color develop-
ment was stopped with HCl and plates were read at
495 nm in a Multiskan EX reader (Thermo Electron).
Results were considered positive, when O.D. of a spe-
cific serum was 3 times higher than a negative control,
which consisted of a serum pool of 7 non atopic patients.
ELISA inhibition assays were conducted in plates pre-
viously coated with 1 μg of protein per well of P. pra-
tense or O. europaea extracts. Two types of sera were
used in the ELISA Inhibition experiments. Serum pool 1
consisted of a mixture of all positive sera (including
serum 11) and contained very low titers of sIgE to rPhl
p 7 and rPhl p 12. It was used at a final dilution of 1/10.
As a control of these inhibition experiments, we also
performed inhibition experiments using another serum
(serum 11) separately, which contained high sIgE titers
to nOle e 1, to rPhl p 1 and rPhl p 5 and to rPhl p 7 and
rPhl p 12 (see Additional file 1: Table S1). Both serum
sources were previously titrated to assure the sensitivity
and comparability of the assay. Serial 2-fold dilutions of
both extracts ranging from 200 μg/ml to 0.01 μg of pro-
tein/ml were used as inhibitors.Mass spectrometry analysis
Mass spectrometry analyses were carried out in the prote-
omic facilities from the Parapléjicos Hospital (Toledo,
Spain), with a previously described method. Briefly,Figure 1 Serum sIgE levels to P. pratense (n = 57), O. europaea (n = 55protein samples were diluted in 8 M urea. After reduc-
tion and alkylation, proteins were trypsin digested. The
peptides were separated on nano-LC system and col-
lected fractions were collected and spotted on a blank
MALDI sample plate. MS and MS/MS analysis of off-
line spotted peptide samples were performed using the
Applied Biosystems 4800 plus MALDI TOF/TOF Analyzer
mass spectrometer. Peptide and protein identifications were
performed using ProteinPilotTM Software V 2.0.1 (Applied
Biosystems) and the Paragon algorithm [17]. MS/MS spec-
trums were searched against different databases (SwissProt
and Uniprot). The confidence percentage calculated by the
software (unused score) reflects the probability of “false posi-
tives”, meaning that at the 90% confidence level, there is a
false positive identification probability of about 10%.
Statistical analysis
The Spearman correlation coefficient was determined
(GrahPad Prism 5.03 Software) to analyze the correlation
coefficients between P. pratense and olive extracts used
in the study.
Results
Skin tests and ImmunoCAP sIgE determination
Skin tests to P. pratense were performed in 65 patients
and were positive in all of them. Skin tests to O. euro-
paea were also performed in 65 patients and 63 were
positive (96.92%). Palm tree profilin was tested in 46 pa-
tients and 41.30% of them had a positive SPT result
(Table 1).
Serum sIgE to P. pratense was positive in all tested pa-
tients (n = 57); rPhl p 1 (n = 55) and rPhl p 5 (n = 57) sIgE
were positive in 95.55% and 58.18%, respectively; rPhl p 7
(n = 43) was positive in 13.95% and rPhl p 12 (n = 45) in
31.11%. Serum sIgE determinations to O. europaea were
positive in all patients and nOle e 1 (n = 55) in 94.54% of
sera tested (Figure 1).
ELISA
Serum sIgE to P. pratense and O. europaea was mea-
sured using ELISA. A positive sIgE determination was) and purified allergens measured by the ImmunoCAP system.
Figure 2 Serum sIgE binding to P. pratense and O. europaea by
ELISA in individual sera.
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dren, respectively. The mean and standard deviation of
sIgE levels (OD) were 2.64 ± 0.97 for P. pratense and
1.26 ± 1.14 for O. europaea (Figure 2).
Cross reactivity assessment
Inhibition assays carried out with O. europaea and P. pratense
did not show any inhibition when serum pool 1 was used
(Figure 3A). However, when serum 11 was used a moder-
ate degree of cross-reactivity was observed between both
extracts (Figure 3B). O. europaea inhibited up to 61% theFigure 3 A) Inhibition ELISAs using a serum pool (pool 1) and an indisIgE binding to P. pratense and P. pratense inhibited up to
33% sIgE binding to O. europaea.
Mass spectrometry
Results revealed the presence of common proteins in O.
europaea and P. pratense extracts. Among the peptides
identified, several belonged to allergenic proteins. MS/
MS analysis also confirmed the existence of at least 42
common proteins in both extracts and the presence of
numerous potential allergenic molecules, which have been
described in other allergen sources (Table 2).
Statistical analysis
No significant correlation was observed between olive
and P. pratense sensitization (r = 0.106; p = 0.4).
Discussion
In this paper we analyzed the in vitro cross-reactivity be-
tween P. pratense and O. europaea using sera from aller-
gic children. The population used in our study had 4
main characteristics. First, they were all children, which
could have affected the overall sensitization pattern; sec-
ond, they all lived in a region where both allergen sources
are clinically relevant; third, 94.5% of the patients were sen-
sitized to Ole e 1, which is a marker of sensitization to
Olive [8] and fourth, the vast majority of the patients
(98.1%, of the patients tested) were also sensitized to grassvidual serum (patient 11) sensitized to panallergens (B).
Table 2 Common proteins identified in O. europaea and
P. pratense extracts by mass spectrometry (n = 42)
Common proteins identified in O. europaea and P. pratense pollen
extracts





70 kDa heat shock cognate protein 2 Luminal binding protein





Ascorbate peroxidase 2 Monodehydroascorbate
reductase
AT1G56340 protein mRNA, clone: RTFL01-12-H18
ATP citrate lyase mRNA, clone: RTFL01-39-D20
ATP-citrate synthase, putative Nucleoside diphosphate
kinase
Auxin-induced protein PCNT115 Os01g0300200 protein
Beta-D-glucosidase Pectinesterase
Calcium binding protein- Calreticulin


















Inorganic pyrophosphatase (Fragment) Uridylate kinase plant,
putative
Isocitrate dehydrogenase [NADP] UTP-glucose-1-phosphate
uridylyltransferase
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1 and 58.2% to Phl p 5. These data are in agreement with
other authors, which have shown a greater prevalence of
sensitization to group 1 than to group 5, in both pediatric
and adult patients [18].
The study by Sekerkova et al. was performed in a
population of grass sensitized children and adults. The
authors demonstrated no significant differences in the
rate of sensitization to Phl p 1 in adults and in children
(90.2% and 93.8%, respectively). However, when compar-
ing patients regarding the prevalence of specific IgE anti-
bodies against Phl p 5, the authors described a 20%
higher incidence of specific antibodies to this allergen inthe group of adults (79.1%) versus children (59.8%). This
incidence found in children by Sekerkova et al. is in ac-
cordance to the results obtained in our study (Table 1).
Strikingly the prevalence of sIgE to the minor allergens
Phl p 7 and Phl p 12 was also very similar in both stud-
ies. Molecular diagnosis supports the hypothesis that
panallergens such as profilins and polcalcins can be con-
sidered as minor allergens in both, olive and grasses,
with a minority of patients sensitized, in variable degrees
to those allergens (13.95% to polcalcin and 31.11% to
profilin). Other approaches that support no cross-reactivity
are the statistical analyses, which show no correlation be-
tween sensitization to olive and the grass species, in spite
of the large number of common proteins as shown by mass
spectrometry results.
We used two serum sources from the same patient
population, who resided in an area where both allergen
sources are important to assess cross-reactivity. Serum
pool 1 contained high levels of sIgE to the major aller-
gens Phl p 1 and Phl p 5 and to Ole e 1 and low levels
to Phl p 7 and Phl p 12. Serum sIgE to olive profilins
and polcalcins could not be analyzed due to a lack of
commercially available reagents. On the other hand, serum
11 contained high sIgE titers to both major allergens in
P. pratense and O. europaea and additionally to Phl p
7 and Phl p 12 was employed as an individual control
and. This serum was the only one with these character-
istics in this patient population, which may represent a
minority of patients. We acknowledge that the use of
only one serum to compare with a serum pool may not
be adequate. However, we believe that serum 11 is rep-
resentative of a group of patients that are highly sensi-
tized to minor and major allergens. Further studies
should evaluate the individual contribution of profilin
and/or polcalcins to the overall clinical sensitivity of
these patients and to the allergenicity of the extracts.
Cross-reactivity studies confirmed 2 different inhib-
ition patterns. It is suggested that if patients are not sen-
sitized to minor allergens, allergen cross-reactivity is
exclusively mediated by major allergens and, therefore,
no cross-reactivity is seen. However, when using a serum
with high sIgE titers to panallergens, the overall cross-
allergenicity of the allergen extracts varies, due to the
contribution and recognition of these minor allergens.
Although we have only shown this phenomenon be-
tween Olive and P. pratense pollen extracts, these find-
ings may be extrapolated to other plant allergen sources,
including fruits, in which the presence of these minor al-
lergens has been demonstrated.
In order to assure that both allergen extracts used in
the cross-reactivity studies were representative, we con-
ducted mass spectrometry analysis. As a result of these
analyses, we confirmed the presence of Phl p 1, Phl p 2,
Phl p 3, Phl p 4, Phl p 5, Phl p 6, Phl p 7, Phl p 11, Phl p
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case of olive pollen, proteomic analysis allowed the iden-
tification of Ole e 1, Ole e 2, Ole e 4, Ole e 5, Ole e 6,
Ole e 9, Ole e 10 and Ole e 11. Surprisingly, Ole e 8 and
Ole e 3 were not identified. This may be due to the low
concentrations of these proteins in the olive pollen ex-
tracts. Except for Ole e 1, which could represent ap-
proximately 20% of the total protein content in the
pollen, other allergens are present in reduced quantities.
This may be the case of Ole e 8, which constitutes less
than 0.05% of the total protein in the extract [19]. An-
other important issue to consider is the location of the
allergen within the pollen grain. It has been shown that
Phl p 1, 4, 5, 6, and 12, were detected in extracts of
pollen and pollen cytoplasmic granules (PCGs), whereas
Phl p 11 was found only in PCGs, and Phl p 2 as well as
Phl p 13 only in pollen extracts [20].
Table 2 summarizes a list of common proteins de-
tected by mass spectrometry in both extracts. This list
contains only those proteins with a confidence percent-
age of 90%. Non allergenic and potentially allergenic
proteins were identified. Potential allergens, which have
been described in other plant and/or non-vegetable sources,
could be responsible of allergenic cross-reactivity between
different species. For instance, triose-phosphate isomerase,
malate hydrogenase and profilins were described as
major allergens in watermelon [21,22]; Triose phos-
phate isomerase was also described in german cock-
roach (Blattella germanica) [23]; Enolase, in latex [24],
Candida albicans [25] Sacharomices cerevisiae [26],
Aspergillus fumigatus [27], Alternaria alternata Cla-
dosporium herbarum [28] and Blattella germanica [23];
Polygalacturonase, in cuppresaceae [29], tomato [30],
and Platanus acerifolia [31] and metylesterase in Sal-
sola kali [32], among others. Interestingly, 1,3-beta-
glucanases were identified in both allergen extracts.
Ole e 9 and Ole e 4 are 1,3-beta-glucanase in Olive
pollen. However, glucanases have not been described
as allergens in grass pollen extracts. Ole e 1-related
proteins were also identified in P. pratense and olive
pollen extracts. However, while Ole e 1 is a major al-
lergen in Olive pollen, Phl p 11, is a minor allergen in
grasses.
Conclusions
Taken into consideration the results of this study, we can
conclude that there is no in vitro cross-reactivity between
O. europaea and P. pratense pollen extracts when using
serum of children mainly sensitized to major allergens and
low levels of sIgE to minor allergens. This kind of patients
represents the majority of the grass sensitized population
in Spain. However, when the serum of a patient highly sen-
sitized to minor allergens was used, some cross-reactivity
could be detected. This fact may have clinical implicationsin the selection of extracts for immunotherapy, and there-
fore, component resolved analysis would be of great help
to identify patients sensitized to minor allergens. To a large
extent, sensitization to olive and grasses is not due to
cross-reactivity but is a consequence of co-sensitization. A
minority of patients recognize common allergens in both
allergen sources in variable degrees.
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units are expressed in kU/L.
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